{
    "url_original": "https://www.wsj.com/articles/fda-eyes-second-covid-19-booster-shot-11645282800?mod=politics_lead_pos5",
    "url": "fda-eyes-second-covid-19-booster-shot-11645282800",
    "title": "FDA Eyes Second Covid-19 Booster Shot",
    "sub_head": "Agency has begun reviewing data that could lead to clearing a second booster dose of the Pfizer, Moderna vaccines in the fall",
    "category_1": "Health",
    "time": "2022-02-19 10:00:00",
    "body": "U.S. health regulators are looking at potentially authorizing a fourth dose of a Covid-19 vaccine in the fall, according to people familiar with the matter.<br />The planning is still in early stages, and authorization would depend on ongoing studies establishing that a fourth dose would shore up peopleâ€™s molecular defenses that waned after their first booster and reduce their risk of symptomatic and severe disease, the people said."
}